Oxford Technology Management

Investor type Micro VC
Founders Lucius Cary

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 130
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 94
Rounds per year 3.33
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Exits 15
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Manufacturing
  • Medical Device
Summary

Oxford Technology Management appeared to be the VC, which was created in 1983. The main department of described VC is located in the Oxford. The venture was found in Europe in United Kingdom.

The real fund results show that this VC is 15 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2005. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year. Opposing the other organizations, this Oxford Technology Management works on 17 percentage points less the average amount of lead investments. The usual things for fund are deals in the range of 1 - 5 millions dollars. The increased amount of exits for fund were in 2017.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Oxford Technology Management, startups are often financed by Innovate UK, UK Innovation & Science Seed Fund, Simon Murdoch. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Oxford Capital Partners, IP Group Plc. In the next rounds fund is usually obtained by Oxford Capital Partners, Hygea VCT, UK Innovation & Science Seed Fund.

This organization was formed by Lucius Cary. We also calculated 3 valuable employees in our database.

For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Gripable, Azellon Cell Therapeutics, Oxis Energy. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Information Technology, Electronics.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Oxford Technology Management:
Typical Co-investors
Oxford Technology Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Oxford Technology Management:

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Applegreen Partners -
British Airways England, London, United Kingdom
Capitol Health Ltd Australia, Docklands, Victoria
Consort Medical Hemel Hempstead, Hertfordshire, United Kingdom
Fifth Province Ventures County Dublin, Dublin, Ireland
Fireca -
Ganexa Capital Lisboa, Lisbon, Portugal
Great Stuff Ventures -
Kunlun Capital Central, Central Region, Singapore
Neglected Climate Opportunities -
New England Partners Massachusetts, Quincy, United States
Nurmiranta Holdings -
Ping An Capital China, Shanghai
PTT Public Company Bangkok, Lat Yao Subdistrict, Thailand
PureTech Health Boston, Massachusetts, United States
TNN Capital Luxembourg, Luxembourg
Winton Labs England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MitoRx Therapeutics

Biotechnology
Therapeutics
25 Apr 2022 Harwell, Oxfordshire, United Kingdom

OxCan

Biotechnology
$1M06 Sep 2021 Oxford, Oxfordshire, United Kingdom

Machine Discovery

Artificial Intelligence
Machine Learning
Software
$2M05 May 2021 Oxford, England, United Kingdom

Lightpoint Medical

Biotechnology
Medical
Medical Device
$7M25 Mar 2021 United Kingdom, England, United Kingdom

Gripable

Health Care
Software
Wellness
$2M24 Mar 2021 London, England, United Kingdom

Oxwash

CleanTech
Laundry and Dry-cleaning
$2M23 Nov 2020 Oxford, England, United Kingdom

Curileum Discovery Ltd

Biotechnology
Pharmaceutical
$280K04 Feb 2020 London Borough of Harrow, England, United Kingdom

Atelerix

Biotechnology
Health Care
Medical
$959K09 May 2019 United Kingdom, England

Curileum Discovery Ltd

Biotechnology
Pharmaceutical
$532K05 Apr 2019 London Borough of Harrow, England, United Kingdom
News
Lightpoint Medical Announces $8 Million in Funding to Support Commercial Launch of its Robotic Cancer Detection Probe

– Lightpoint Medical announced that it has completed an $8m financing round.
– The funding includes follow-on investment from private investors, Oxford Technology, Venture Founders, Coutts Bank, and new funding from the British Business Bank Future Fund.
– The new capital will be used to finance expanded clinical trials and early commercialization of Lightpoint’s robotic probe, SENSEI®, which has the potential to assist in over 2 million applicable surgical procedures every year in the EU, US, China and Japan.
– SENSEI® received CE Mark approval at the beginning of the year, has been registered successfully with the FDA, and has received approval for sale in Australia.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Oxford Technology Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: